Specifically, Wang et al. found that the expression levels of the immune checkpoint genes (ICGs) PDCD1 (the gene encoding PD-1) and CTLA-4 were significantly higher in HCC samples compared to normal liver tissues, and the high expression levels of ICGs in HCC patients may be correlated with poorer prognosis. This evidence concerns the gene CTLA4 and hepatocellular carcinoma.